United States

Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

2 Dec 2016
Change (% chg)

Rs-1.15 (-0.16%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Select another date:

Mon, Nov 28 2016

BRIEF-Sun Pharma Industries launches first branded ophthalmic product Bromsite in USA

* Announcement of launches first branded ophthalmic product Bromsite in USA

BRIEF-Sun Pharma enters into deal to buy 85.1 pct of Russia's JSC Biosintez

* Says company has entered into an agreement to acquire 85.1% of JSC Biosintez, a Russian pharmaceutical company

UPDATE 2-Sun Pharma expects U.S. drug pricing pressures to continue

* Says expects pricing pressure in U.S. to continue (Adds comments from conference call)

BRIEF-India's Sun Pharma says unsure if Halol plant will be cleared in next 5 months

* India's Sun Pharma said it was unsure if Halol plant would be cleared in the next five months, as the FDA may take time Further company coverage: (Reporting By Zeba Siddiqui)

BRIEF-Sun Pharmaceutical Industries exec says pricing pressure in the U.S. will continue

* Sun Pharmaceutical Industries exec says awaiting US FDA reinspection of Halol plant

India's Sun Pharma Q2 profit beats estimates

MUMBAI, Nov 10 Sun Pharmaceutical Industries Ltd , India's largest drugmaker, reported on Thursday a quarterly profit that more than doubled from last year, outpacing analysts' expectations.

BRIEF-Sun Pharmaceutical Industries approves amalgamation of 4 units into co

* Says approves scheme of amalgamation of Sun Pharma Medisales, Ranbaxy Drugs Ltd, Gufic Pharma, Vidyut Investments into co Source text: http://bit.ly/2g0Jbpb Further company coverage:

BRIEF-Sun Pharmaceutical Industries on track to achieve benefits from Ranbaxy acquisition

* Sun Pharmaceutical Industries Ltd says synergies from the Ranbaxy acquisition are gaining momentum and co on track to achieve the targeted benefits

BRIEF-Sun Pharmaceutical Industries Sept-qtr profit more than doubles

* Consensus forecast for Sep-qtr consol profit was 16.46 billion rupees

BRIEF-Tianjin Chase Sun Pharma to invest 170 mln yuan in biopharma technology firm in Jiangsu

* Says it signs agreement to invest 170 million yuan ($25.09 million) in biopharma technology firm in Jiangsu province

Select another date: